{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Wertenauer C"],"pubmed_abstract":["<h4>Background</h4>Rapid diagnostic testing for SARS-Cov-2 antigens is used to combat the ongoing pandemic. In this study we aimed to compare two RDTs, the SD Biosensor Q SARS-CoV-2 Rapid Antigen Test (Roche) and the Panbio COVID-19 Ag Rapid Test (Abbott), against rRT-PCR.<h4>Methods</h4>We included 2,215 all-comers at a diagnostic center between February 1 and March 31, 2021. rRT-PCR-positive samples were examined for SARS-CoV-2 variants.<h4>Findings</h4>Three hundred and thirty eight participants (15%) were rRT-PCR-positive for SARS-CoV-2. The sensitivities of Roche-RDT and Abbott-RDT were 60.4 and 56.8% (<i>P</i> < 0.0001) and specificities 99.7% and 99.8% (<i>P</i> = 0.076). Sensitivity inversely correlated with rRT-PCR-Ct values. The RDTs had higher sensitivities in individuals referr"],"journal":["Frontiers in medicine"],"pagination":["774550"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8979030"],"repository":["biostudies-literature"],"pubmed_title":["Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study."],"pmcid":["PMC8979030"],"pubmed_authors":["Marz W","Mutschmann C","Moissl AP","Hauser U","Wertenauer C","Wieland E","Mayer C","Wertenauer HJ","Brenner Michael G","Roskos M","Dressel A","Pfeifer C","Lorkowski S"],"additional_accession":[]},"is_claimable":false,"name":"Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study.","description":"<h4>Background</h4>Rapid diagnostic testing for SARS-Cov-2 antigens is used to combat the ongoing pandemic. In this study we aimed to compare two RDTs, the SD Biosensor Q SARS-CoV-2 Rapid Antigen Test (Roche) and the Panbio COVID-19 Ag Rapid Test (Abbott), against rRT-PCR.<h4>Methods</h4>We included 2,215 all-comers at a diagnostic center between February 1 and March 31, 2021. rRT-PCR-positive samples were examined for SARS-CoV-2 variants.<h4>Findings</h4>Three hundred and thirty eight participants (15%) were rRT-PCR-positive for SARS-CoV-2. The sensitivities of Roche-RDT and Abbott-RDT were 60.4 and 56.8% (<i>P</i> < 0.0001) and specificities 99.7% and 99.8% (<i>P</i> = 0.076). Sensitivity inversely correlated with rRT-PCR-Ct values. The RDTs had higher sensitivities in individuals referr","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T23:34:41.081Z","creation":"2025-04-04T23:34:41.081Z"},"accession":"S-EPMC8979030","cross_references":{"pubmed":["35386920"],"doi":["10.3389/fmed.2022.774550"]}}